Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TRiCares Topaz Transfemoral Tricuspid Heart Valve Replacement System First in Human Trial

NCT05126030 is registered in ClinicalTrials.gov with TRiCares as lead sponsor.

NCT NCT05126030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05126030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TRiCares Topaz Transfemoral Tricuspid Heart Valve Replacement System First in Human Trial
Lead sponsor
TRiCares
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 15, 2022
Completion date
May 15, 2029
Enrollment
20 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

tricuspid regurgitation